Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.

Market Analysis and Insights: Global Antibiotic Resistance Market
The global Antibiotic Resistance market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Antibiotic Resistance Scope and Market Size
The global Antibiotic Resistance market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibiotic Resistance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
By Disease
By Pathogen

Segment by Application
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other

The Antibiotic Resistance market is analysed and market size information is provided by regions (countries). Segment by Application, the Antibiotic Resistance market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Allergan
AmpliPhi Biosciences
BioVersys GmbH
Macrolide Pharmaceuticals
Melinta Therapeutics
Merck
Nabriva Therapeutics
Nemesis Bioscience
Phage Technologies S.A
Tetraphase Pharmaceuticals
The Medicines Company
TPfizer
Westway Health